"Our findings challenge the idea that uveitis is driven by T cells alone and show that B cells may also be playing an important role," says Dr. Jebson. Moreover, in a mouse model of uveitis, the ...
MDX2003 targets CD19 and CD20 on B cells and CD3 and CD28 on T cells, enhancing antitumor activity and reducing antigen loss. The therapy's design limits cytokine release syndrome, showing improved ...
Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results